Amedisys (AMED) PT Raised to $350 at RBC Capital
Tweet
Share
E-mailGet Alerts AMED Hot Sheet
Price: $100.99 --0%
Rating Summary:
6 Buy, 15 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
6 Buy, 15 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
RBC Capital analyst Frank Morgan raised the price target on Amedisys (NASDAQ: AMED) to $350.00 (from $335.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Citi Downgrades Lend Lease Group (LLC:AU) (LLESY) to Neutral
- Citi Upgrades Angel Yeast Co Ltd (600298:CH) to Buy
- Perseus Mining Limited (PRU:AU) (PMNXF) PT Lowered to AUD6.80 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
